Eyegenex is a pharmaceutical company that develops drugs for blindness.
Eyegenex has raised $745K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Eyegenex's investors include Newsight Tech Angels.
Eyegenex is headquartered in La Jolla, United States.
Eyegenex is a pharmaceutical company that develops drugs for blindness.
Eyegenex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyegenex — Funding & Investors." VCBacked, September 6, 2026, https://www.vcbacked.co/company/eyegenex. Accessed October 1, 2026.
VCBacked. (2026). Eyegenex — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/eyegenex
{{cite web |title=Eyegenex — Funding & Investors |url=https://www.vcbacked.co/company/eyegenex |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated